Skip to main content

Free shipping over $200.

For research use only

Tesamorelin 10 mg research peptide vial

Tesamorelin

GHRH Analog Peptide for Growth Hormone Related Receptor Signaling Research

  • Third-party tested
  • COA available
  • Lyophilized research material

Description

Tesamorelin is a synthetic analog of growth-hormone-releasing hormone (GHRH) investigated for its interaction with the GHRH receptor. It is intended for laboratory investigation of receptor-mediated growth hormone axis signaling.

Vial strength

$120.00/ 10 mg · USD

Volume pricing

Applied automatically in the cart

Per-unit price by quantity. The row in force is marked.
QuantityPer unitYou save
3–4 units$114.00−5%
5–9 units$108.00−10%
10+ units$102.00−15%

Add 2 more to save 5% on every unit.

Quantity
1

SKU VP-TESA-10

Purity stated per lot

Figures are reported against the lot they belong to, never as a brand average. The analysis for a batch is published on that batch’s certificate.

  • Certificate published for each batch
  • Third-party tested
  • Orders over $200 ship free
  • Supplied for laboratory research use only

Complete your protocol

Lyophilized vials are supplied dry. Add the accompanying laboratory supplies in one step.

  • TesamorelinThis item

Nothing selected

$0.00

Supplied as laboratory materials for research use only.

Scientific overview

Tesamorelin is a synthetic analog derived from growth-hormone-releasing-hormone peptide research. It has been modified at the N-terminus to increase resistance to enzymatic degradation while preserving receptor binding. Tesamorelin has been investigated for its interaction with the growth hormone-releasing hormone receptor and downstream endocrine signaling. Researchers may use it to investigate GHRH receptor activation and pituitary signaling within an experimental model.

Research applications

  • GHRH receptor signaling
  • Growth hormone axis research
  • Pituitary signaling models
  • Endocrine peptide research
  • Receptor interaction studies
  • Hormone-signaling pathways
  • IGF-1 pathway research
  • Peptide stability research

Research use & regulatory disclaimer

All products offered by viopep are intended solely for laboratory research and analytical purposes. viopep products are not intended for human or veterinary use or consumption.

Products offered by viopep have not been approved by the U.S. Food and Drug Administration (FDA) for the diagnosis, treatment, cure, mitigation, or prevention of any disease or medical condition. Products are not intended to be used as drugs, food products, dietary supplements, cosmetics, or household products.

Information provided on this website is for general informational and research purposes only. Nothing on this website is intended to constitute medical advice, diagnosis, treatment recommendations, dosing instructions, or guidance regarding human or veterinary use.

By purchasing from viopep, the purchaser acknowledges that products are intended solely for legitimate research purposes and agrees to use and handle all products in accordance with applicable laws, regulations, and appropriate laboratory safety procedures.

Specifications

Specifications for Tesamorelin
CompoundTesamorelin
Compound TypeSynthetic GHRH analog
Primary TargetGHRH receptor
Research CategoryEndocrine & Receptor Signaling
Catalog strengths10 mg / 20 mg
SKUVP-TESA-10 / VP-TESA-20
PurityPublished on the certificate for each batch
Analytical methodPublished on the certificate for each batch
Testing laboratoryPublished on the certificate for each batch
FormLyophilized research material

Storage and handling

Store lyophilized at -20°C; protect from light and moisture. Reconstitute with bacteriostatic water; refrigerate reconstituted solution at 2-8°C.